BRIEF published on 08/06/2024 at 22:10, 2 years 2 months ago Nyxoah Reports Financial Results for Q2 and H1 2024 Revenue Growth Capital Raise Operational Highlights FDA Submission Q2 2024 Results
PRESS RELEASE published on 08/06/2024 at 22:05, 2 years 2 months ago Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results Nyxoah SA reports financial and operating results for the second quarter and first half of 2024, including FDA submission completion and U.S. approval progress Financial Results Operating Results FDA Submission Nyxoah SA U.S. Approval
BRIEF published on 07/15/2024 at 08:20, 2 years 3 months ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer FDA Approval Medical Device Industry Nyxoah Obstructive Sleep Apnea Scott Holstine
PRESS RELEASE published on 07/15/2024 at 08:15, 2 years 3 months ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer Nyxoah appoints Scott Holstine as Chief Commercial Officer, bringing 26 years of medical device industry experience. His role is crucial for Nyxoah's U.S. launch success in treating Obstructive Sleep Apnea Chief Commercial Officer Medical Technology Nyxoah Obstructive Sleep Apnea Scott Holstine
BRIEF published on 07/03/2024 at 12:35, 2 years 3 months ago Nyxoah Signs €37.5 Million Loan Agreement with European Investment Bank Loan Agreement Medical Technology European Investment Bank Nyxoah Obstructive Sleep Apnea
PRESS RELEASE published on 07/03/2024 at 12:30, 2 years 3 months ago Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Nyxoah signs a €37.5 million loan facility agreement with the European Investment Bank to boost research, development, and manufacturing capacity for sleep apnea solutions Research And Development European Investment Bank Sleep Apnea Nyxoah €37.5 Million Loan
Published on 10/24/2026 at 00:04, 2 days 6 hours ago Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 2 days 6 hours ago Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 2 days 8 hours ago Apex Closes Offering and Completes NASDAQ Listing
Published on 10/23/2026 at 16:00, 2 days 14 hours ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/26/2026 at 02:05, 4 hours 5 minutes ago Tin Men Capital leads US$7.4M Series A for Vision AI startup Ailytics to expand across APAC, US and Gulf
Published on 10/24/2026 at 23:44, 1 day 6 hours ago EQS-Adhoc: HomeToGo SE: Unauthorized data exfiltration at subsidiary SECRA Bookings GmbH
Published on 10/24/2026 at 14:15, 1 day 15 hours ago Winners of the 2026 INPD Awards Announced, C-Beauty Takes Home Multiple Prestigious Honors
Published on 10/24/2026 at 06:30, 1 day 23 hours ago AI and EV Boom Draws $690 Million in Advanced Materials Investment Plans to Thailand
Published on 10/23/2026 at 18:55, 2 days 11 hours ago Qatar's Years of Culture Initiative Announces Partner Countries Through 2030
Published on 10/23/2026 at 20:33, 2 days 9 hours ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 2 days 12 hours ago Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
Published on 10/22/2026 at 18:00, 3 days 12 hours ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 3 days 12 hours ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
